How to Get Skinoren Online in Ireland
Need Skinoren in Ireland? Complete a secure online medical questionnaire with photo upload. An EU doctor reviews your case in under 24 hours for a 40 € flat fee, backed by a 100% money-back guarantee.
DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
If you want to get Skinoren online in Ireland, you do not need to wait weeks for a local GP appointment or dermatologist referral. Through Hi-Doctor, you complete a quick clinical questionnaire and upload photos of your skin from home. An EU-licensed doctor reviews your submission and, when clinically appropriate, issues an official European REMPE prescription in under 24 hours for a flat 40 € fee. You pay with zero financial risk: if our doctor determines the treatment is not suitable for you, your 40 € is refunded in full.
How it works — get your consultation in 4 steps
Getting your prescription through Hi-Doctor is entirely digital, private, and RGPD-compliant. You can complete the process in minutes from your phone or computer.
- Complete the medical questionnaire: Answer targeted questions about your breakout patterns, skin sensitivity, past treatments, and current health status.
- Upload skin photographs: Provide clear, well-lit photos of the affected areas so the EU doctor can evaluate lesion morphology and severity accurately.
- Doctor clinical assessment: An EU-licensed doctor reviews your file and, when clinically appropriate, issues an official REMPE digital prescription in under 24 hours.
- Present at your pharmacy: Download your prescription PDF from your patient portal or email. Print it out or show it on your phone at your local pharmacy in Ireland, where the pharmacist reviews the order and may dispense azelaic acid 15% gel (Skinoren).
Who qualifies
Skinoren contains azelaic acid 15% gel and is indicated for mild-to-moderate inflammatory acne vulgaris and papulopustular rosacea. Because it is non-photosensitising and carries a very low risk of post-inflammatory hyperpigmentation, it is widely recommended for darker skin phototypes and patients who cannot tolerate retinoids.
Hi-Doctor provides consultations strictly for outpatient topical dermatology. Patients presenting with severe nodulocystic acne, extensive scarring, or systemic symptoms are out of scope and are referred directly to in-person clinical care.
| Condition & Severity | Topical Treatment Options | Hi-Doctor Online Pathway |
|---|---|---|
| Mild-to-moderate inflammatory acne | Azelaic acid 15% gel (Skinoren) / Adapalene + BPO | Eligible for doctor review |
| Papulopustular rosacea | Azelaic acid 15% gel / Compounded topical formulas | Eligible for doctor review |
| Epidermal melasma & hyperpigmentation | Azelaic acid 15% / Compounded depigmenting creams | Eligible for doctor review |
| Severe nodulocystic or scarring acne | Oral isotretinoin (Roaccutane) / Oral antibiotics | Out of scope (Referred to in-person care) |
Over 50,000 patients have accessed clinical care through Hi-Doctor, backed by an independent 4.8/5 Trustpilot rating.
What Skinoren actually does
Skinoren (azelaic acid 15% gel) provides a targeted dual-action mechanism against acne lesions. It acts as a comedolytic agent by normalising follicular keratinisation, which prevents dead epidermal cells from plugging pores. Simultaneously, it exerts direct antibacterial properties against Cutibacterium acnes without causing bacterial resistance.
Consistency is vital when using topical azelaic acid twice daily. Patients should anticipate a standard therapeutic timeline:
- Weeks 1–2: Skin begins adjusting to the formulation; transient tingling or dryness may occur.
- Weeks 2–6: Mild purging or cellular turnover can bring sub-surface microcomedones to the surface.
- Week 12: Meaningful clinical reduction in inflammatory papules, pustules, and redness is formally evaluated.
Side effects and when to stop
Azelaic acid 15% gel is generally gentle, but mild local cutaneous irritation is normal when initiating therapy. Most symptoms resolve within 2 to 4 weeks as your epidermal barrier adapts.
- Common initial reactions: Mild stinging, burning, itching, or superficial flaking at the application site.
- Barrier management: Apply a light, non-comedogenic moisturiser before applying Skinoren, or reduce application to once daily until tolerance develops.
- When to stop: Discontinue treatment immediately and seek urgent medical evaluation if you experience severe contact dermatitis, facial swelling, hives, or breathing difficulty.
Why Hi-Doctor vs. walking into a clinic
Booking a GP appointment in Ireland often entails long waiting times, while private dermatologists frequently have waiting lists spanning months. Hi-Doctor offers a direct, legally recognised pathway for routine dermatological prescriptions.
| Feature | Hi-Doctor Consultation | Traditional In-Person Clinic |
|---|---|---|
| Consultation cost | 40 € flat one-off | 60 € – 250 € (GP or specialist) |
| Review turnaround | Under 24 hours | Days to months wait time |
| Money-back guarantee | 100% refund if not prescribed | None (fee charged regardless) |
| Prescription standard | Cross-border REMPE e-prescription PDF | Paper or national health script |
| Medication dispensing | Presented at any Irish pharmacy | Presented at local pharmacy |
Prescriptions issued through Hi-Doctor use Spain's official REMPE electronic framework, structured for cross-border recognition under Directive 2011/24/EU with mandatory fields specified by Commission Implementing Directive 2012/52/EU.
COMMON QUESTIONS
Frequently asked questions
Yes. Under EU Directive 2011/24/EU, prescriptions issued by an EU-licensed medical practitioner must be recognised in other EU Member States, including Ireland. Your REMPE prescription PDF includes all necessary prescriber and product information required by Commission Implementing Directive 2012/52/EU. Irish pharmacists review the prescription and may dispense Skinoren or a locally marketed bioequivalent, though dispensing discretion always remains with the individual pharmacist.
